GI Innovation Inc
KOSDAQ:358570
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oi SA em Recuperacao Judicial
OTC:OIBZQ
|
BR |
|
N
|
Newton Resources Ltd
HKEX:1231
|
HK |
|
A
|
Atlas Cycles (Haryana) Ltd
NSE:ATLASCYCLE
|
IN |
GI Innovation Inc
Accrued Liabilities
GI Innovation Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GI Innovation Inc
KOSDAQ:358570
|
Accrued Liabilities
₩456.9m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Celltrion Inc
KRX:068270
|
Accrued Liabilities
₩191.8B
|
CAGR 3-Years
2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Accrued Liabilities
₩52.6B
|
CAGR 3-Years
20%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Accrued Liabilities
₩449.2m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Accrued Liabilities
₩375m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
4%
|
CAGR 10-Years
18%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Accrued Liabilities
₩462.2m
|
CAGR 3-Years
36%
|
CAGR 5-Years
36%
|
CAGR 10-Years
N/A
|
|
GI Innovation Inc
Glance View
GI Innovation, Inc. engages in the development of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 88 full-time employees. The company went IPO on 2023-03-30. The firm is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
See Also
What is GI Innovation Inc's Accrued Liabilities?
Accrued Liabilities
456.9m
KRW
Based on the financial report for Dec 31, 2024, GI Innovation Inc's Accrued Liabilities amounts to 456.9m KRW.
What is GI Innovation Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
16%
Over the last year, the Accrued Liabilities growth was -46%. The average annual Accrued Liabilities growth rates for GI Innovation Inc have been 16% over the past three years .
